Boston Scientific Corporation Acquires Asthmatx for $443,500,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b3953bff-f9ae-4a01-b2f4-7239c0c7d0a3&Preview=1 - Date
9/20/2010 - Company Name
Asthmatx - Mailing Address
888 Ross Drive Sunnyvale, CA 94089 - Company Description
Asthmatx, Inc. is focused on helping patients with asthma breathe easier. We are developing an interventional medical device, called the Alair System, for the bronchoscopic treatment of patients with moderate to severe asthma. Multiple clinical studies are underway to evaluate the safety and efficacy of this device in potentially improving the lives of patients with asthma. One of these studies, the Air2Trial is presently enrolling patients. - Website
http://www.asthmatx.com - Transaction Type
M&A - Transaction Amount
$443,500,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
The deal is worth $193.5 million in cash plus up to $250 million more based on revenue-based earnout.
